John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Woodward
WWD
$20.3B
| $11.4M | 0.03% |
91,332
+10,684
| +13% | +$1.26M |
|
552
Clover Health Investments
CLOV
$2.2B
| $11.4M | 0.03% |
3,212,109
-3,397,519
| -51% | -$9.85M |
|
553
Hubbell
HUBB
$24.8B
| $11.3M | 0.03% |
61,758
+60,005
| +3,423% | +$11.3M |
|
554
Franklin Templeton
BEN
$17.4B
| $11.3M | 0.03% |
405,230
-59,778
| -13% | -$1.83M |
|
555
W.R. Berkley
WRB
$25.5B
| $11.3M | 0.03% |
254,757
+42,823
| +20% | +$1.71M |
|
556
Golar LNG
GLNG
$5.31B
| $11.2M | 0.03% |
+451,398
| New | +$7.45M |
|
557
Ironwood Pharmaceuticals
IRWD
$709M
| $11.2M | 0.03% |
+888,888
| New | +$10.2M |
|
558
GoodRx Holdings
GDRX
$1.18B
| $11.2M | 0.03% |
578,238
+357,745
| +162% | +$8.2M |
|
559
American Electric Power
AEP
$65.8B
| $11.2M | 0.03% |
111,959
-255,115
| -69% | -$23.3M |
|
560
Royal Bank of Canada
RY
$285B
| $11.2M | 0.03% |
101,267
-674,253
| -87% | -$75.6M |
|
561
Harmony Biosciences
HRMY
$2.22B
| $11.1M | 0.03% |
228,000
+216,491
| +1,881% | +$8.83M |
|
562
TAL Education Group
TAL
$6.28B
| $11M | 0.03% |
3,651,146
-3,407,192
| -48% | -$10.5M |
|
563
Voya Financial
VOYA
$8.86B
| $11M | 0.03% |
165,585
-37,929
| -19% | -$2.59M |
|
564
Schrodinger
SDGR
$1.47B
| $10.9M | 0.03% |
320,495
-227,741
| -42% | -$6.92M |
|
565
Xerox
XRX
$381M
| $10.9M | 0.03% |
541,178
-1,375,942
| -72% | -$28.9M |
|
|
TWTR
566
DELISTED
Twitter, Inc.
TWTR
| $10.9M | 0.03% |
281,668
-4,867,168
| -95% | -$178M |
|
567
CareDx
CDNA
$2.51B
| $10.9M | 0.03% |
293,364
+7,984
| +3% | +$311K |
|
568
iShares MSCI USA Quality Factor ETF
QUAL
$47.7B
| $10.9M | 0.03% |
80,600
-194,000
| -71% | -$25.8M |
|
569
Nabors Industries
NBR
$1.37B
| $10.8M | 0.03% |
70,966
+36,837
| +108% | +$4.63M |
|
570
Roblox
RBLX
$27.4B
| $10.8M | 0.03% |
+232,843
| New | +$14M |
|
|
NGD
571
DELISTED
New Gold Inc
NGD
| $10.7M | 0.03% |
5,956,991
+1,243,330
| +26% | +$2.14M |
|
572
Park Hotels & Resorts
PK
$3.18B
| $10.7M | 0.03% |
547,772
-87,785
| -14% | -$1.65M |
|
573
A.O. Smith
AOS
$8.57B
| $10.7M | 0.03% |
166,867
+62,002
| +59% | +$4.51M |
|
574
Grid Dynamics Holdings
GDYN
$649M
| $10.6M | 0.03% |
+753,567
| New | +$15.4M |
|
575
Banco Bradesco
BBD
$33.9B
| $10.5M | 0.03% |
2,496,040
+2,363,460
| +1,783% | +$8.67M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.